[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kong et al., 2016 - Google Patents

Sweet pharmaceutical salts of stanozolol with enhanced solubility and physical stability

Kong et al., 2016

Document ID
7215117575982825761
Author
Kong M
Fu X
Li J
Li J
Chen M
Deng Z
Zhang H
Publication year
Publication venue
CrystEngComm

External Links

Snippet

Different solid forms of stanozolol (STAN), including two polymorphs, one monohydrate, and a large number of solvates and cocrystals had been reported previously. In this contribution, two pharmaceutical salts of STAN with artificial sweeteners, saccharin (SAC) and …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, -CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups

Similar Documents

Publication Publication Date Title
Aitipamula et al. Novel solid forms of the anti-tuberculosis drug, Isoniazid: Ternary and polymorphic cocrystals
Kong et al. Sweet pharmaceutical salts of stanozolol with enhanced solubility and physical stability
Sowa et al. A 1: 1 pharmaceutical cocrystal of myricetin in combination with uncommon piracetam conformer: X-ray single crystal analysis and mechanochemical synthesis
WO2016091221A1 (en) Salt of pyrrolo[2,3-d]pyrimidine compound and novel polymorph of salt
JP2021121597A (en) PHARMACEUTICALLY ACCEPTABLE SALTS OF β-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
Wang et al. 2: 1 5-Fluorocytosine–acesulfame CAB cocrystal and 1: 1 5-fluorocytosine–acesulfame salt hydrate with enhanced stability against hydration
US10927142B2 (en) Salts and polymorphs of SCY-078
CN104470920A (en) Solid state form of vemurafenib choline salt
Wu et al. New insight into improving the solubility of poorly soluble drugs by preventing the formation of their hydrogen-bonds: A case of dapsone salts with camphorsulfonic and 5-sulfosalicylic acid
WO2015170345A1 (en) Pharmaceutical cocrystals of gefitinib
JP2020502190A (en) Crystal salts and polymorphs of P2X3 antagonists
CA2900951A1 (en) Solid state forms of vemurafenib hydrochloride
CN109776430B (en) Sulfadimidine eutectic crystal and preparation method thereof
ES2738638T3 (en) Cabozantinib salts and their use as anticancer agents
CN112209887B (en) Eutectic crystal of 5-fluorouracil and kaempferol and preparation method thereof
CN104105699B (en) The solid form of (1r, 4r)-6 '-fluoro-N, N-dimethyl-4-phenyl-4 ', 9 '-dihydro-3 ' H-spiral shell [hexamethylene-1,1 '-pyrans also [3,4, b] indole]-4-amine hydrochlorate
CN112538123A (en) Crystal form M of sugammadex sodium
CN112538124A (en) Crystal form of sugammadex sodium
CA3108007A1 (en) Highly stable crystalline eltrombopag monoethanolamine salt form d1
Stepanovs et al. Molecular salts of propranolol with dicarboxylic acids: diversity of stoichiometry, supramolecular structures and physicochemical properties
CA2944150A1 (en) Polymorphic forms and co-crystals of a c-met inhibitor
Zhang et al. New bedaquiline salt with improved bioavailability and reduced food effect
WO2024022998A1 (en) Process for preparing daprodustat and cocrystals thereof
KR20230155499A (en) Crystalline salts of multi-tyrosine kinase inhibitors, methods of preparation, and uses thereof
GOLOB et al. The definitive version is available at